Clinical, cosmetic and investigational dermatology · 2026
Insulin Resistance as a Potential Predictor of Post-Inflammatory Hyperpigmentation After CO2 Laser Resurfacing: A Real-World Study of a Dual Technique Protocol (Maghreb Experience).
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Benosman Sihem, Zhao Qiaofeng, Ran Yuping, Huang Xueqin, Leguina-Ruzzi Alberto
Аннотация
PURPOSE: Laser-assisted skin regeneration is a cornerstone of modern dermatologic practice; however, post-inflammatory hyperpigmentation (PIH) remains a major limiting complication of CO2 laser treatments. Risk has traditionally been attributed to darker phototypes, particularly in high ultraviolet (UV) exposure settings. Emerging evidence suggests that metabolic factors, especially insulin resistance measured by HOMA-IR, may influence pigmentary responses. This study evaluated a Dual Technique CO2 laser protocol designed to enhance skin regeneration while reducing the number of treatment sessions and explored the association between PIH and metabolic status.
PATIENTS AND METHODS: A prospective, non-randomized, real-world study included 45 patients treated in a private practice in the Maghreb region, characterized by high UV exposure and predominantly medium-to-high phototypes. The Dual Technique combined ablative fractional vaporization with subablative thermal stimulation. Skin quality was assessed using the Vancouver Scar Scale (VSS), and PIH severity using the Dermal Pigmentation Area and Severity Index (DPASI). Outcomes were analyzed in relation to phototype, HOMA-IR, and polycystic ovary syndrome (PCOS).
RESULTS: Significant clinical improvement was observed across indications following treatment, typically within two sessions. PIH occurred in 15/20 (75%) patients with Fitzpatrick phototypes I-III compared with 9/25 (36%) patients with phototypes IV-VI (p = 0.0092). PIH severity showed a strong positive correlation with HOMA-IR (Spearman ρ = 0.8624, p < 0.0001). PCOS prevalence did not differ significantly between phototype groups (p = 0.8). PIH improved significantly following standardized management.
CONCLUSION: The Dual Technique CO2 laser protocol was associated with favorable clinical outcomes using relatively few treatment sessions. In this cohort, higher HOMA-IR was strongly associated with greater PIH severity, suggesting that insulin resistance may represent an additional factor associated with individual PIH susceptibility. These findings are hypothesis-generating and require confirmation in larger, controlled studies before metabolic assessment can be recommended for routine laser-treatment risk stratification.
PATIENTS AND METHODS: A prospective, non-randomized, real-world study included 45 patients treated in a private practice in the Maghreb region, characterized by high UV exposure and predominantly medium-to-high phototypes. The Dual Technique combined ablative fractional vaporization with subablative thermal stimulation. Skin quality was assessed using the Vancouver Scar Scale (VSS), and PIH severity using the Dermal Pigmentation Area and Severity Index (DPASI). Outcomes were analyzed in relation to phototype, HOMA-IR, and polycystic ovary syndrome (PCOS).
RESULTS: Significant clinical improvement was observed across indications following treatment, typically within two sessions. PIH occurred in 15/20 (75%) patients with Fitzpatrick phototypes I-III compared with 9/25 (36%) patients with phototypes IV-VI (p = 0.0092). PIH severity showed a strong positive correlation with HOMA-IR (Spearman ρ = 0.8624, p < 0.0001). PCOS prevalence did not differ significantly between phototype groups (p = 0.8). PIH improved significantly following standardized management.
CONCLUSION: The Dual Technique CO2 laser protocol was associated with favorable clinical outcomes using relatively few treatment sessions. In this cohort, higher HOMA-IR was strongly associated with greater PIH severity, suggesting that insulin resistance may represent an additional factor associated with individual PIH susceptibility. These findings are hypothesis-generating and require confirmation in larger, controlled studies before metabolic assessment can be recommended for routine laser-treatment risk stratification.